DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 080229
NDA 080229 describes NAPHCON FORTE, which is a drug marketed by Alcon and is included in one NDA. Additional details are available on the NAPHCON FORTE profile page.
The generic ingredient in NAPHCON FORTE is naphazoline hydrochloride. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride profile page.
The generic ingredient in NAPHCON FORTE is naphazoline hydrochloride. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride profile page.
Summary for 080229
| Tradename: | NAPHCON FORTE |
| Applicant: | Alcon |
| Ingredient: | naphazoline hydrochloride |
| Patents: | 0 |
| Therapeutic Class: | Ophthalmic Agents |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 080229
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
